Addrenex Pharmaceuticals Report issue

For profit Phase 2 Phase 3
Founded: Durham NC United States (2006)
Status: Acquired by Shionogi (2009)

Organization Overview

First Clinical Trial
2007
NCT00556959
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Addrenex | Addrenex Pharmaceuticals, Inc.